| Title : Bioavailability Study of a Transdermal Patch Formulation of Rivastigmine Compared with Exelon in Healthy Subjects - Morte_2022_Eur.J.Drug.Metab.Pharmacokinet__ |
| Author(s) : Morte A , Vaque A , Iniesta M , Schug B , Koch C , de la Torre R , Schurad B |
| Ref : Eur J Drug Metab Pharmacokinet , : , 2022 |
| Abstract : Morte_2022_Eur.J.Drug.Metab.Pharmacokinet__ |
| ESTHER : Morte_2022_Eur.J.Drug.Metab.Pharmacokinet__ |
| PubMedSearch : Morte_2022_Eur.J.Drug.Metab.Pharmacokinet__ |
| PubMedID: 35696054 |
| Title : Comparative Bioavailability study of a Novel Multi-day Patch Formulation of Rivastigmine (twice weekly) with Exelon Transdermal Patch (daily). A randomized clinical trial - Schurad_2022_Curr.Alzheimer.Res__ |
| Author(s) : Schurad B , Koch C , Schug B , Morte A , Vaque A , de la Torre R , Iniesta M |
| Ref : Curr Alzheimer Res , : , 2022 |
| Abstract : Schurad_2022_Curr.Alzheimer.Res__ |
| ESTHER : Schurad_2022_Curr.Alzheimer.Res__ |
| PubMedSearch : Schurad_2022_Curr.Alzheimer.Res__ |
| PubMedID: 36017827 |